This time last year Andrea James was spending time with her young family, going to yoga twice a week and generally taking the slow approach to life. Today, she is CFO at Nasdaq-listed Oncocyte, a molecular diagnostics technology company.
James explains that when she first decided to take a career break – at the time she was chief communications officer and IR head at alternative defense firm Axon – she didn’t know what she wanted to do next. ‘I needed to get out of the day-to-day of being at a rapid-growth company, in a highly visible role . . .
Log in FOR FREE to access this content
Log in or create your free My IR – Essentials account to:
- Access 50+ deep dives and best practice reports
- View 100+ news analyses and our exclusive CFO series
- Instantly benchmark your IR program with our new tool
- Save favorites and get tailored content delivered to your dashboard
- 10% off all IR forums!
Join now to make a real impact in your organization.
